Results 31 to 40 of about 50,394 (243)

Causes, Diagnosis, Risk Stratification and Treatment of Bicuspid Aortic Valve Disease: An Updated Review. [PDF]

Cardiol Res, 2020
The most common congenital heart disease is the bicuspid aortic valve. Understanding the pathophysiology and the altered hemodynamics is a key component for the diagnosis, risk stratification and treatment. Among others, aortic valve stenosis is the most
Sakellaropoulos S, Mohammed M, Svab S, Lekaditi D, Sakellaropoulos P, Mitsis A.   +5 more
europepmc   +2 more sources

Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease. [PDF]

J Soc Cardiovasc Angiogr Interv, 2022
Ahmad Y, Agarwal V, Williams ML, Wang DD, Reardon MJ, Cavalcante JL, Makkar R, Forrest JK.   +7 more
europepmc   +3 more sources

Bicuspid aortic valve disease - the influence of valve morphotype on age at and types of surgical treatment. [PDF]

Int J Cardiol Heart Vasc, 2021
Lim MS, Celermajer DS, Bannon PG.
europepmc   +2 more sources

Defects in the Exocyst-Cilia Machinery Cause Bicuspid Aortic Valve Disease and Aortic Stenosis. [PDF]

Circulation, 2019
BACKGROUND Bicuspid aortic valve (BAV) disease is a congenital defect that affects 0.5-1.2% of the population and is associated with co-morbidities including ascending aortic dilation and calcific aortic valve stenosis (CAVS). To date, while a few causal
Fulmer D, Toomer K, Guo L, Moore K, Glover J, Moore R, Stairley R, Lobo G, Zuo X, Dang Y, Su Y, Fogelgren B, Gerard P, Chung D, Heydarpour M, Mukherjee R, Body SC, Norris RA, Lipschutz JH.   +18 more
europepmc   +2 more sources

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease [PDF]

Journal of the American College of Cardiology, 2014
BACKGROUND Limited information exists describing the results of transcatheter aortic valve (TAV) replacement in patients with bicuspid aortic valve (BAV) disease (TAV-in-BAV). OBJECTIVES This study sought to evaluate clinical outcomes of a large cohort of patients undergoing TAV-in-BAV.
Darren Mylotte, Thierry Lefèvre, Lars Søndergaard, Yusuke Watanabe, Thomas Modine, Danny Dvir, Johan Bosmans, Didier Tchétché, Ran Kornowski, Jan‐Malte Sinning, Pascal Thériault-Lauzier, Cróchán J. O’Sullivan, Marco Barbanti, Nicolas Debry, Jean Buithieu, Pablo Codner, Magdalena Dorfmeister, Giuseppe Martucci, Georg Nickenig, Peter Wenaweser, Corrado Tamburino, Eberhard Grube, John G. Webb, Stephan Windecker, Rüediger Lange, Nicolò Piazza   +25 more
openalex   +6 more sources

Outcomes in Bicuspid Aortic Valve Disease.

Journal of the American College of Cardiology, 2023
R. Pai
semanticscholar   +3 more sources

Cardiac Mesenchymal Stem Cell-like Cells Derived from a Young Patient with Bicuspid Aortic Valve Disease Have a Prematurely Aged Phenotype. [PDF]

Biomedicines, 2022
Oldershaw RA, Richardson G, Carling P, Owens WA, Lundy DJ, Meeson A.   +5 more
europepmc   +3 more sources

Identifying Patients with Bicuspid Aortic Valve Disease in UK Primary Care: A Case-Control Study and Prediction Model. [PDF]

J Pers Med, 2022
Evans W, Akyea RK, Weng S, Kai J, Qureshi N.   +4 more
europepmc   +3 more sources

Bicuspid aortic valve: The most frequent and not so benign congenital heart disease

Cardiovascular pathology
Gaetano Thiene, Stefania Rizzo, Cristina Basso   +2 more
openalex   +2 more sources

Stentless valves for bicuspid and tricuspid aortic valve disease [PDF]

JTCVS Open, 2021
To determine long-term survival and reoperation rate in patients with a bicuspid aortic valve (BAV) and patients with a tricuspid aortic valve (TAV) after stentless aortic valve replacement (AVR)/aortic root replacement (ARR).Between 1992 and 2014, 1293 patients underwent first AVR/ARR with a stentless aortic valve using the modified inclusion ...
Brown, Bailey, Le, Tan, Naeem, Aroma, Malik, Aroosa, Norton, Elizabeth L., Wu, Xiaoting, Patel, Himanshu J., Deeb, G. Michael, Kim, Karen M., Yang, Bo   +9 more
openaire   +2 more sources